Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension

Published:2023-10 Issue:10 Volume:8 Page:1379-1388
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Valentine Michael S.,Bender Aaron M.,Shay Sheila,Paffenroth Krista C.,Gladson Santhi,Dickerson Jonathan W.,Watson Katherine J.,Kapolka Nicholas J.,Boutaud Olivier,Rook Jerri M.,Blackwell Timothy S.,Roth Bryan L.,Harrison Fiona E.,Austin Eric D.,West James D.,Lindsley Craig W.,Merryman W. David

Funder

NHLBI

William K. Warren Foundation

NICHD

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Pulmonary arterial hypertension in France: results from a national registry;Humbert;Am J Respir Crit Care Med,2006

2. for the French Pulmonary Arterial Hypertension Network. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension;Humbert;Eur Respir J,2010

3. Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed;Macchia;Am Heart J,2010

4. Pulmonary arterial hypertension: pathogenesis and clinical management;Thenappan;BMJ,2018

5. International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension;Abenhaim;N Engl J Med,1996

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscular hyperplasia in Crohn’s disease strictures: through thick and thin;American Journal of Physiology-Cell Physiology;2024-09-01

2. Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression;JACC: Basic to Translational Science;2024-07

3. Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists;ACS Medicinal Chemistry Letters;2024-01-19

4. Inhibiting Serotonin to Treat Pulmonary Arterial Hypertension;JACC: Basic to Translational Science;2023-10